Life Quote by Jonathan Slack
““The FDA will accept a certain level of risk for a new treatment that is to be applied to a group of very sick patients who would otherwise die in the near future, but not for a group who have a relatively long life expectancy on the basis of existing therapies.””
About This Quote
Regulatory bodies accept higher risk for terminal patients but not for those with longer life expectancy, highlighting ethical risk thresholds.
In simple terms: FDA allows more risk for dying patients than for those likely to live longer.
Key Takeaway
Consider risk tolerance based on patient prognosis.
Themes
ethics
risk
medical regulation
Mood
analytical
thoughtful
Type
informational
ethical
When to use this quote
- clinical trials
- end‑of‑life treatments
- life‑prolonging therapies
Key Concepts
bioethics
patient care
Questions to Reflect On
- How should risk be weighed for different patient groups?
- What safeguards ensure fairness in treatment approval?
A Different Perspective
Balancing risk and benefit is complex and context‑dependent.
